to what we refer to as 'moderate-medicalisation', we argue that a less 'older-age-focused'
aid services, have been suggested. In agreement with this, we argue that approaches to 23 reduce hearing loss stigma should be prioritised. However, we propose a reduced form of 24 medicalisation, rather than a de-medicalised, approach is required. Furthermore, in addition 25 to what we refer to as 'moderate-medicalisation', we argue that a less 'older-age-focused'
26
NHS hearing service will facilitate earlier access to assessment and hearing technology. We 27 suggest some service delivery changes that will promote moderate-medicalisation and an age- NHS hearing services is to be achieved.
33
 A less medicalised and less 'older-age-focused' NHS hearing aid service will reduce 34 stigma and facilitate earlier access.
35
 Changes to NHS hearing services that promote moderate-medicalisation and age-36 neutrality are recommended. To this end, and following a series of workshops for audiologists, patients and members of 79 the public during which the medicalised approach of hearing services was raised by attendees 80 as a potential barrier to access and HA uptake, within this paper we provide an overview of 81 the concept of medicalisation and hearing loss stigma in the context of NHS HA services.
82
Following this we make a number of suggestions for service changes that address stigma by 83 reducing the medicalised and old-age focused sub-culture of NHS HA services, and argue for 84 'moderate medicalisation' and an age-neutral environment. Therefore, given the negatives as well as the positives of medicalisation (and de-146 medicalisation) we suggest changes to service delivery that will make NHS HA services less 147 medicalised and less "older-age-focused", rather than totally de-medicalised. We call this 
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